The Scientific World Journal

The Scientific World Journal / 2009 / Article
Special Issue

Sexual Dysfunction

View this Special Issue

Mini-Review Article | Open Access

Volume 9 |Article ID 137949 |

Arnold Melman, Kelvin P. Davies, "Gene Therapy in the Management of Erectile Dysfunction (ED): Past, Present, and Future", The Scientific World Journal, vol. 9, Article ID 137949, 9 pages, 2009.

Gene Therapy in the Management of Erectile Dysfunction (ED): Past, Present, and Future

Academic Editor: Ricardo Munarriz
Received07 Apr 2009
Revised06 Aug 2009
Accepted17 Aug 2009


In the past, many researchers considered viral vectors to be the most promising candidates to transfer genetic material into the corpora for the treatment of erectile dysfunction. However, at present, no viral vectors have progressed to human trials. In contrast, the use of naked gene therapy, a plasmid expressing the human Maxi-K potassium channel, is the only gene therapy treatment to be evaluated in clinical phase I trials to date. The success of these studies, proving the safety of this treatment, has paved the way for the development of future gene transfer techniques based on similar transfer methods, as well as novel treatment vectors, such as stem cell transfer.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.